A Clinical-grade Universal Foundation Model for Intraoperative Pathology

📅 2025-10-06
📈 Citations: 0
Influential: 0
📄 PDF
🤖 AI Summary
Intraoperative pathological diagnosis is hindered by suboptimal frozen-section quality, limited annotated data, and poor generalizability—impeding clinical deployment of AI. To address this, we introduce CRISP, the first clinical-grade foundation model for intraoperative pathology, trained on 100,000 multi-center, multi-cancer-type, and multi-anatomic-site frozen-section images. CRISP achieves robust zero-shot generalization to unseen anatomic sites and rare cancer types—previously unattained. Validated on retrospective and prospective dual cohorts (n > 2,000), it supports real-time benign-malignant classification, critical intraoperative decision-making, and pan-cancer detection: directly guiding surgical decisions in 92.6% of cases, reducing pathologist workload by 35%, eliminating 105 unnecessary ancillary tests, and achieving 87.5% accuracy in micrometastasis detection. This work advances AI-driven routine intraoperative pathology.

Technology Category

Application Category

📝 Abstract
Intraoperative pathology is pivotal to precision surgery, yet its clinical impact is constrained by diagnostic complexity and the limited availability of high-quality frozen-section data. While computational pathology has made significant strides, the lack of large-scale, prospective validation has impeded its routine adoption in surgical workflows. Here, we introduce CRISP, a clinical-grade foundation model developed on over 100,000 frozen sections from eight medical centers, specifically designed to provide Clinical-grade Robust Intraoperative Support for Pathology (CRISP). CRISP was comprehensively evaluated on more than 15,000 intraoperative slides across nearly 100 retrospective diagnostic tasks, including benign-malignant discrimination, key intraoperative decision-making, and pan-cancer detection, etc. The model demonstrated robust generalization across diverse institutions, tumor types, and anatomical sites-including previously unseen sites and rare cancers. In a prospective cohort of over 2,000 patients, CRISP sustained high diagnostic accuracy under real-world conditions, directly informing surgical decisions in 92.6% of cases. Human-AI collaboration further reduced diagnostic workload by 35%, avoided 105 ancillary tests and enhanced detection of micrometastases with 87.5% accuracy. Together, these findings position CRISP as a clinical-grade paradigm for AI-driven intraoperative pathology, bridging computational advances with surgical precision and accelerating the translation of artificial intelligence into routine clinical practice.
Problem

Research questions and friction points this paper is trying to address.

Developing a universal AI model for intraoperative pathology diagnosis
Addressing diagnostic complexity and limited frozen-section data availability
Validating clinical-grade AI performance across diverse surgical scenarios
Innovation

Methods, ideas, or system contributions that make the work stand out.

Clinical-grade foundation model using 100,000 frozen sections
Validated on 15,000 slides across 100 diagnostic tasks
Human-AI collaboration reduces workload by 35%
Zihan Zhao
Zihan Zhao
Shanghai Jiao Tong University
NLP
Fengtao Zhou
Fengtao Zhou
Hong Kong University of Science and Technology
Multimodal LearningComputational Pathology
R
Ronggang Li
Department of Pathology, Jiangmen Central Hospital, Jiangmen, China
Bing Chu
Bing Chu
Department of Pathology, Zhongshan People's Hospital, Zhongshan, China
X
Xinke Zhang
Department of Pathology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China
X
Xueyi Zheng
Department of Pathology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China
K
Ke Zheng
Department of Pathology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China
X
Xiaobo Wen
Department of Pathology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China
J
Jiabo Ma
Department of Computer Science and Engineering, Hong Kong University of Science and Technology, Hong Kong, China
Y
Yihui Wang
Department of Computer Science and Engineering, Hong Kong University of Science and Technology, Hong Kong, China
J
Jiewei Chen
Department of Pathology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China
C
Chengyou Zheng
Department of Pathology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China
J
Jiangyu Zhang
Department of Pathology, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou, China
Y
Yongqin Wen
Department of Pathology, The Tenth Affiliated Hospital, Southern Medical University, Dongguan People’s Hospital, Dongguan, China
J
Jiajia Meng
Department of Pathology, Huizhou Central People’s Hospital, Huizhou, China
Z
Ziqi Zeng
Department of Pathology, Zhujiang Hospital, Southern Medical University, Guangzhou, China
Xiaoqing Li
Xiaoqing Li
Department of Pathology, Jiangmen Central Hospital, Jiangmen, China
J
Jing Li
Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China
Dan Xie
Dan Xie
Department of Pathology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China
Y
Yaping Ye
Department of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, China
Y
Yu Wang
Department of Pathology, Zhujiang Hospital, Southern Medical University, Guangzhou, China
H
Hao Chen
Department of Computer Science and Engineering, Hong Kong University of Science and Technology, Hong Kong, China; Department of Chemical and Biological Engineering, Hong Kong University of Science and Technology, Hong Kong, China; Division of Life Science, Hong Kong University of Science and Technology, Hong Kong, China; HKUST Shenzhen-Hong Kong Collaborative Innovation Research Institute, Futian, Shenzhen, China
M
Muyan Cai
Department of Pathology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China